News and Press

January 12, 2023
Sonablate Corp. Appoints Dr. Samuel Peretsman to Medical Director and Board of Directors
Sonablate Corp., a global leader in minimally-invasive focused ultrasound technologies, today announced Dr. Samuel Peretsman has joined the organization as Medical Director and has been appointed to its Board of Directors as a Board Member...
January 5, 2023
Sonablate Corp. Announces Extended Agreement with HIFU Prostate Services (HPS) to be a National Mobile Provider
Sonablate Corp., a world leader in minimally invasive focused ultrasound technologies, today announced a three-year agreement with HIFU Prostate Services (HPS)...
November 15, 2022
Sonablate Corp. Announces 3-Year Agreement with Agiliti to be a National Mobile Provider
Sonablate Corp., a world leader in minimally invasive focused ultrasound technologies, today announced a 3-year agreement with Agiliti...
November 2, 2022
Sonablate Corp. Announces Increased Reimbursement Rate for Sonablate HIFU Procedure from the Centers for Medicare & Medicaid Services (CMS)
The Centers for Medicare & Medicaid Services (CMS) issued a final rule that will update policies and payment rates under the OPPS and ASC...
October 3, 2022
Sonablate Corp. Announces Support for the Focal Therapy Society
Sonablate Corp., a world leader in minimally invasive focused ultrasound technologies, announced sponsorship support for the Focal Therapy Society...
July 18, 2022
Sonablate Corp. Announces Support for Centers for Medicare & Medicaid Services (CMS) proposed increase in reimbursement rates for Sonablate HIFU procedure
Sonablate Corp., a world leader in minimally invasive focused ultrasound technologies, announces support for Centers for Medicare & Medicaid Services (CMS) proposed rule...
July 6, 2022
Three separate clinicians told Paul Sayer that focal therapy was not an option for his prostate disease. Turns out, that was not true.
Sonablate Corp. Announces Support for Paul’s charity, Prost8 UK and the ONE in EIGHT Campaign and Advocacy for Education on Minimally Invasive Treatment Options for Prostate Diseases...
June 2, 2022
Sonablate Corp. Receives NMPA Approval in China to treat Benign Prostatic Hyperplasia (BPH)
Sonablate Corp., a world leader in minimally invasive focused ultrasound technologies, announces expanded regulatory approval from the National Medical Products Administration...
May 18, 2022
Research Utilizing Sonablate HIFU Recognized in Award Winning Session During The 2022 American Urological Association (AUA) Annual Meeting
CHARLOTTE, NC, USA, May 18, 2022 /EINPresswire.com/-- Sonablate Corp., a world leader in minimally invasive focused ultrasound technologies...
February 7, 2022
Sonablate Corp. announces publication of clinical data supporting the use of Sonablate HIFU
CHARLOTTE, NC, USA, February 7, 2022 /EINPresswire.com/-- Sonablate Corp., a world leader in minimally invasive focused ultrasound...
January 18, 2022
Sonablate Corp. signed exclusive distribution agreement with CanAm Scientific for the GCC Territory
CHARLOTTE, NC, USA, January 18, 2022 /EINPresswire.com/ -- Sonablate Corp., a world leader in minimally invasive focused ultrasound...
August 15, 2021
SONACARE MEDICAL ANNOUNCES SIGNIFICANT PUBLICATION OF FOCAL THERAPY COMPARISON TO RADICAL THERAPY
SONACARE MEDICAL ANNOUNCES SIGNIFICANT PUBLICATION OF FOCAL THERAPY COMPARISON TO RADICAL THERAPY This study used propensity matching to...
August 15, 2021
SONACARE MEDICAL ANNOUNCES PURCHASE AT MAYO CLINIC
SONACARE MEDICAL ANNOUNCES PURCHASE AT MAYO CLINIC Charlotte, NC (EIN Newswire) [January 22, 2021] – SonaCare Medical, the leading...
August 15, 2021
SONABLATE CORP ANNOUNCES FORMATION, OVER $70M IN COMBINED SEED INVESTMENT AND DISTRIBUTION AGREEMENT
SONABLATE CORP. ANNOUNCES FORMATION, OVER $70M IN COMBINED SEED INVESTMENT AND DISTRIBUTION AGREEMENT SALES TO ACCELERATE GLOBAL HIFU...